Providing market intelligence for more than 35 years

In The News

Most Broadband Homes Have Pay-TV and OTT Subscriptions

More than half of all U.S. homes with broadband subscribe to both a pay-TV service and at least one over-the-top video service, according to a new study by Parks Associates.

In its OTT Video & TV Everywhere: Partners, Alternatives and Competition report, Parks says that 53% of broadband homes subscribe to both pay TV and OTT.

“Many OTT services are evolving to be complementary to the market’s largest players, instead of trying to compete directly against Netflix, Amazon, and Hulu,” said Brett Sappington, senior director of research, Parks Associates. “Also, consumers are increasingly self-aggregating their OTT and entertainment services—they are adopting primary entertainment content sources and supplementing those sources with complementary video options.”

From the article "Most Broadband Homes Have Pay-TV and OTT Subscriptions" by Jon Lafayette. 

Previously In The News

Comcast says traditional TV viewing is up, but subscribers are down across the board

According to a recent report on TV viewership from Parks Associates, 20% of US broadband households don't have a pay-TV service, while 12% of those homes cut the cord in 2018. The report found that f...

Cord-Cutting On The Rise In The US

“Pay TV subscriptions have dropped each year since 2014, falling to 81% of US broadband households in Q3 2016,” said Brett Sappington, senior director of research, Parks Associates. “Several factor...

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...